Cite
HARVARD Citation
Sachchithanantham, S. et al. (2017). Immunoparesis defined by heavy+light chain suppression is a novel marker of long‐term outcomes in cardiac AL amyloidosis. British journal of haematology. pp. 575-585. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sachchithanantham, S. et al. (2017). Immunoparesis defined by heavy+light chain suppression is a novel marker of long‐term outcomes in cardiac AL amyloidosis. British journal of haematology. pp. 575-585. [Online].